Tempest Therapeutics Stock (NASDAQ: TPST) stock price, news, charts, stock research, profile.
Open | $2.18 |
Close | $2.19 |
Volume / Avg. | 841.41K / 1.35M |
Day Range | 2.14 - 2.25 |
52 Wk Range | 0.17 - 9.77 |
Market Cap | $47.99M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 27 |
Short Interest | 8.98% |
Days to Cover | 4.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Other companies in Tempest Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), CARISMA Therapeutics (NASDAQ:CARM), Curis (NASDAQ:CRIS), Immuneering (NASDAQ:IMRX) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for Tempest Therapeutics.
Tempest Therapeutics has a consensus price target of $16.17.
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $2.16 last updated June 28, 2024 at 5:44 PM EDT.
There are no upcoming dividends for Tempest Therapeutics.
Tempest Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Tempest Therapeutics.
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.